De Quervain's thyroiditis

Last updated
De Quervain's thyroiditis
Other namesGiant cell thyroiditis, subacute granulomatous thyroiditis
Subacute thyroiditis - intermed mag.jpg
Micrograph showing a granuloma in subacute thyroiditis. H&E stain.
Specialty Endocrinology   OOjs UI icon edit-ltr-progressive.svg

De Quervain's thyroiditis, also known as subacute granulomatous thyroiditis or giant cell thyroiditis,is a self-limiting inflammatory illness of the thyroid gland. [1] De Quervain thyroiditis is characterized by fever, flu-like symptoms, a painful goiter, and neck pain. The disease has a natural history of four phases: thyroid pain, thyrotoxicosis, euthyroid phase, hypothyroid phase, and recovery euthyroid phase.

Contents

De Quervain's thyroiditis has been linked to various diseases, including mumps, adenovirus, and enterovirus. It may have a hereditary component, with two-thirds of patients having positive histocompatibility antigen (HLA) B35 results. Atypical cases have HLA B15/62 positivity, and it is more common in summer or fall months in people who test positive for HLA B67.

De Quervain thyroiditis is diagnosed through clinical and test results, with laboratory features including elevated C-reactive protein and erythrocyte sedimentation rate. Thyroid function testing often shows decreased thyroid stimulating hormone and increased serum levels of triiodothyronine and thyroxine during the acute phase. Thyroid scans show minimal uptake during the acute phase due to disrupted thyroid follicles, but increase during recovery due to the thyroid gland's enhanced iodine trapping capacity. Thyroid ultrasonography typically shows thyroid gland enlargement and hypoechogenicity, while color Doppler ultrasonography may show low or normal vascular flow. Tissue diagnosis is rare, but fine needle aspiration may be helpful in questionable cases to differentiate unilateral involvement from bleeding into a cyst or tumor.

Signs and symptoms

Patients typically present with low-grade fever and flu-like symptoms such as sore throat, myalgia, arthralgia, and malaise, which are followed by high-grade fever, a painful, widespread goiter, and neck pain. [2] The neck pain is usually unilateral at first, then spreads to the other side and can radiate to the ipsilateral jaw, ear, occiput, or chest. [3] [4] Other symptoms, such as dysphagia and breathing difficulties caused by airway blockage, are uncommon. [2]

The thyroid gland is extremely painful, rigid, and swollen, which can be symmetrical or asymmetrical. [2] Approximately half of affected adolescents and two-thirds of adults have widespread thyroid gland involvement. [3] [5] Thyroid nodules are seen in one-fourth of adult patients. [6] The surrounding skin is occasionally warm and erythematous. Cervical lymphadenopathy is rare. [2] During the early stages of the condition, almost half of patients experience thyrotoxic symptoms such as anxiety, tachycardia, palpitation, and weight loss. [7] [8]

The typical natural history of de Quervain thyroiditis has four phases, beginning with thyroid discomfort and thyrotoxicosis, followed by a brief euthyroid phase, temporary hypothyroid phase, and recovery euthyroid phase. [7]

Causes

De Quervain's thyroiditis has been linked to a variety of viral illnesses, including mumps, [9] adenovirus, [10] Epstein-Barr virus, [11]  cytomegalovirus, [12] coxsackievirus, [13]  influenza, [10] echovirus, [14] and enterovirus. [15]

Furthermore, the development of de Quervain thyroiditis may have a hereditary component. [2] About two thirds of patients with de Quervain thyroiditis were found to have positive histocompatibility antigen (HLA) B35 results. [16] [17] Furthermore, it was found that identical twins who were heterozygous for the HLA B35 haplotype also developed de Quervain thyroiditis at the same time. [18] Atypical cases of de Quervain thyroiditis have also been documented to have HLA B15/62 positivity, [19] and summer or fall months are when de Quervain thyroiditis is more common in people who test positive for HLA B67. [20]

Mechanism

It's still unclear exactly what causes de Quervain thyroiditis. According to available data, it is not an autoimmune illness. Still, the most likely cause is a viral infection. [2] One theory for the pathophysiology of virus-associated thyroiditis is that thyroid follicular cell destruction results from cytotoxic T cell identification of viral and cell antigens presented as a complex. [15] [21]

Diagnosis

The most common methods for diagnosing de Quervain thyroiditis are clinical and test results. [2] Elevations of C-reactive protein and erythrocyte sedimentation rate are laboratory features of the condition. [3] While typically normal, the blood leukocyte count may be slightly increased. There may be anemia that is normochromic and normocytic. Thyroid function testing frequently reveals decreased thyroid stimulating hormone (TSH) and increased serum levels of triiodothyronine (T3) and thyroxine (T4) during the acute phase of the disease. [2] The intrathyroidal T3 and T4 levels are often reflected by the T3 to T4 ratio, which is typically less than 20 (ng/dL divided by μg/dL). [22] Nearly all patients have increased serum thyroglobulin, which is consistent with follicular destruction. [23]

Thyroid scans using technetium (99mTc) pertechnetate or RAIU usually show minimal uptake during the acute phase. This happens when thyroid follicles are disrupted, which impairs iodine trapping. [2] Thyroid scan uptake increases throughout the recovery phase due to the thyroid gland's enhanced capacity to trap iodine, which eventually returns to normal after full recovery. [7]

Thyroid gland enlargement and a region of hypoechogenicity that correlates to the inflammatory area are typically seen on thyroid ultrasonography. [24] Low or normal vascular flow may be shown by color Doppler ultrasonography. [25]

Rarely is tissue diagnosis required. Fine needle aspiration may be helpful in questionable cases, such as the area of pain restricted to a single nodule or confined area, to differentiate unilateral involvement from bleeding into a cyst or tumor. [26]

Treatment

The goals of treatment are to lessen hyperthyroid symptoms and relieve discomfort. Pain control only necessitates symptomatic treatment with non-steroidal anti-inflammatory medications or aspirin. [2] Severely sick individuals may benefit from glucocorticoid medication, which often produces a substantial response in 24 to 48 hours. [4] Thyrotoxic symptoms are managed with beta-adrenergic blockers such atenolol and propranolol. [2]

Related Research Articles

<span class="mw-page-title-main">Hyperthyroidism</span> Clinical syndrome caused by excessive thyroid hormone

Hyperthyroidism is the condition that occurs due to excessive production of thyroid hormones by the thyroid gland. Thyrotoxicosis is the condition that occurs due to excessive thyroid hormone of any cause and therefore includes hyperthyroidism. Some, however, use the terms interchangeably. Signs and symptoms vary between people and may include irritability, muscle weakness, sleeping problems, a fast heartbeat, heat intolerance, diarrhea, enlargement of the thyroid, hand tremor, and weight loss. Symptoms are typically less severe in the elderly and during pregnancy. An uncommon but life-threatening complication is thyroid storm in which an event such as an infection results in worsening symptoms such as confusion and a high temperature; this often results in death. The opposite is hypothyroidism, when the thyroid gland does not make enough thyroid hormone.

<span class="mw-page-title-main">Hypothyroidism</span> Endocrine disease

Hypothyroidism is a disorder of the endocrine system in which the thyroid gland does not produce enough thyroid hormones. It can cause a number of symptoms, such as poor ability to tolerate cold, extreme fatigue, muscle aches, constipation, slow heart rate, depression, and weight gain. Occasionally there may be swelling of the front part of the neck due to goitre. Untreated cases of hypothyroidism during pregnancy can lead to delays in growth and intellectual development in the baby or congenital iodine deficiency syndrome.

Thyroid-stimulating hormone (also known as thyrotropin, thyrotropic hormone, or abbreviated TSH) is a pituitary hormone that stimulates the thyroid gland to produce thyroxine (T4), and then triiodothyronine (T3) which stimulates the metabolism of almost every tissue in the body. It is a glycoprotein hormone produced by thyrotrope cells in the anterior pituitary gland, which regulates the endocrine function of the thyroid.

<span class="mw-page-title-main">Hashimoto's thyroiditis</span> Autoimmune disease

Hashimoto's thyroiditis, also known as chronic lymphocytic thyroiditis and Hashimoto's disease, is an autoimmune disease in which the thyroid gland is gradually destroyed. A slightly broader term is autoimmune thyroiditis, identical other than that it is also used to describe a similar condition without a goiter.

Ord's thyroiditis is an atrophic form of chronic thyroiditis, an autoimmune disease where the body's own antibodies fight the cells of the thyroid.

<span class="mw-page-title-main">Thyroid disease</span> Medical condition

Thyroid disease is a medical condition that affects the function of the thyroid gland. The thyroid gland is located at the front of the neck and produces thyroid hormones that travel through the blood to help regulate many other organs, meaning that it is an endocrine organ. These hormones normally act in the body to regulate energy use, infant development, and childhood development.

<span class="mw-page-title-main">Thyroiditis</span> Medical condition

Thyroiditis is the inflammation of the thyroid gland. The thyroid gland is located on the front of the neck below the laryngeal prominence, and makes hormones that control metabolism.

Thyroid storm is a rare but severe and life-threatening complication of hyperthyroidism. It occurs when an overactive thyroid leads to hypermetabolism, which can cause death from cardiac arrest or multiple organ failure.

The quantitative insulin sensitivity check index (QUICKI) is derived using the inverse of the sum of the logarithms of the fasting insulin and fasting glucose:

<span class="mw-page-title-main">Adrenocorticotropic hormone deficiency</span> Medical condition

Adrenocorticotropic hormone deficiency is a rare disorder characterized by secondary adrenal insufficiency with minimal or no cortisol production and normal pituitary hormone secretion apart from ACTH. ACTH deficiency may be congenital or acquired, and its symptoms are clinically similar to those of glucocorticoid deficiency. Symptoms consist of weight loss, diminished appetite, muscle weakness, nausea, vomiting, and hypotension. Low blood sugar and hyponatremia are possible; however, blood potassium levels typically remain normal because affected patients are deficient in glucocorticoids rather than mineralocorticoids because of their intact renin-angiotensin-aldosterone system. ACTH may be undetectable in blood tests, and cortisol is abnormally low. Glucocorticoid replacement therapy is required. With the exception of stressful situations, some patients with mild or nearly asymptomatic disease may not require glucocorticoid replacement therapy. As of 2008 about two hundred cases have been described in the literature.

<span class="mw-page-title-main">Subacute thyroiditis</span> Medical condition

Subacute thyroiditis refers to a temporal classification of the different forms of thyroiditis based on onset of symptoms. The temporal classification of thyroiditis includes presentation of symptoms in an acute, subacute, or chronic manner. There are also other classification systems for thyroiditis based on factors such as clinical symptoms and underlying etiology.

Postpartum thyroiditis refers to thyroid dysfunction occurring in the first 12 months after pregnancy and may involve hyperthyroidism, hypothyroidism or the two sequentially. According to the National Institute of Health, postpartum thyroiditis affects about 8% of pregnancies. There are, however, different rates reported globally. This is likely due to the differing amounts of average postpartum follow times around the world, and due to humans' own innate differences. For example, in Bangkok, Thailand the rate is 1.1%, but in Brazil it is 13.3%. The first phase is typically hyperthyroidism. Then, the thyroid either returns to normal or a woman develops hypothyroidism. Of those women who experience hypothyroidism associated with postpartum thyroiditis, one in five will develop permanent hypothyroidism requiring lifelong treatment.

<span class="mw-page-title-main">Hypothalamic–pituitary–thyroid axis</span> Part of the neuroendocrine system

The hypothalamic–pituitary–thyroid axis is part of the neuroendocrine system responsible for the regulation of metabolism and also responds to stress.

Euthyroid sick syndrome (ESS) is a state of adaptation or dysregulation of thyrotropic feedback control wherein the levels of T3 and/or T4 are abnormal, but the thyroid gland does not appear to be dysfunctional. This condition may result from allostatic responses of hypothalamus-pituitary-thyroid feedback control, dyshomeostatic disorders, drug interferences, and impaired assay characteristics in critical illness.

<span class="mw-page-title-main">Autoimmune polyendocrine syndrome type 2</span> Medical condition

Autoimmune polyendocrine syndrome type 2, a form of autoimmune polyendocrine syndrome also known as APS-II, or PAS II, is the most common form of the polyglandular failure syndromes. PAS II is defined as the association between autoimmune Addison's disease and either autoimmune thyroid disease, type 1 diabetes, or both. It is heterogeneous and has not been linked to one gene. Rather, individuals are at a higher risk when they carry a particular human leukocyte antigen. APS-II affects women to a greater degree than men.

Thyroid disease in pregnancy can affect the health of the mother as well as the child before and after delivery. Thyroid disorders are prevalent in women of child-bearing age and for this reason commonly present as a pre-existing disease in pregnancy, or after childbirth. Uncorrected thyroid dysfunction in pregnancy has adverse effects on fetal and maternal well-being. The deleterious effects of thyroid dysfunction can also extend beyond pregnancy and delivery to affect neurointellectual development in the early life of the child. Due to an increase in thyroxine binding globulin, an increase in placental type 3 deioidinase and the placental transfer of maternal thyroxine to the fetus, the demand for thyroid hormones is increased during pregnancy. The necessary increase in thyroid hormone production is facilitated by high human chorionic gonadotropin (hCG) concentrations, which bind the TSH receptor and stimulate the maternal thyroid to increase maternal thyroid hormone concentrations by roughly 50%. If the necessary increase in thyroid function cannot be met, this may cause a previously unnoticed (mild) thyroid disorder to worsen and become evident as gestational thyroid disease. Currently, there is not enough evidence to suggest that screening for thyroid dysfunction is beneficial, especially since treatment thyroid hormone supplementation may come with a risk of overtreatment. After women give birth, about 5% develop postpartum thyroiditis which can occur up to nine months afterwards. This is characterized by a short period of hyperthyroidism followed by a period of hypothyroidism; 20–40% remain permanently hypothyroid.

<span class="mw-page-title-main">Thyroid's secretory capacity</span>

Thyroid's secretory capacity is the maximum stimulated amount of thyroxine that the thyroid can produce in a given time-unit.

Autoimmune polyendocrine syndrome, type 3 is a condition characterized by the coexistence of autoimmune thyroiditis and at least one other autoimmune disease. Based on other organ-specific autoimmune involvement, there are multiple subtypes that are classified: type 3a shows thyroid autoimmune disease in conjunction with type 1 diabetes, type 3b shows thyroid autoimmune disease in conjunction with pernicious anemia (PA), and type 3c shows thyroid autoimmune disease in conjunction with alopecia, vitiligo, or other organ-specific autoimmune disease.

<span class="mw-page-title-main">Amiodarone induced thyrotoxicosis</span> Form of hyperthyroidism

Amiodarone induced thyrotoxicosis (AIT) is a form of hyperthyroidism due to treatment with antiarrhythmic drug, amiodarone.

<span class="mw-page-title-main">Hypothyroidism in dogs</span> Medical condition

Hypothyroidism is an endocrine disorder in which the thyroid gland fails to produce sufficient thyroid hormones. Hypothyroidism is one of the most common endocrinopathies in dogs. It is either acquired or congenital.

References

  1. ↑ Engkakul, Pontipa; Mahachoklertwattana, Pat; Poomthavorn, Preamrudee (2011). "de Quervain thyroiditis in a young boy following hand–foot–mouth disease". European Journal of Pediatrics. 170 (4): 527–529. doi:10.1007/s00431-010-1305-5. ISSN   0340-6199.
  2. 1 2 3 4 5 6 7 8 9 10 11 Engkakul, Pontipa; Mahachoklertwattana, Pat; Poomthavorn, Preamrudee (2011). "Eponym: de Quervain thyroiditis". European Journal of Pediatrics. 170 (4): 427–431. doi:10.1007/s00431-010-1306-4. ISSN   0340-6199.
  3. 1 2 3 Greene, James N. (1971). "Subacute thyroiditis". The American Journal of Medicine. 51 (1). Elsevier BV: 97–108. doi:10.1016/0002-9343(71)90327-5. ISSN   0002-9343.
  4. 1 2 Volpé, Robert (1993). "The Management of Subacute (DeQuervain's) Thyroiditis". Thyroid. 3 (3): 253–255. doi:10.1089/thy.1993.3.253. ISSN   1050-7256.
  5. ↑ Ogawa, E.; Katsushima, Y.; Fujiwara, I.; Iinuma, K. (2003). "Subacute Thyroiditis in Children: Patient Report and Review of the Literature". Journal of Pediatric Endocrinology and Metabolism. 16 (6). Walter de Gruyter GmbH. doi:10.1515/jpem.2003.16.6.897. ISSN   2191-0251.
  6. ↑ Fatourechi, Vahab; Aniszewski, Jaroslaw P.; Fatourechi, Guiti Z. Eghbali; Atkinson, Elizabeth J.; Jacobsen, Steven J. (2003-05-01). "Clinical Features and Outcome of Subacute Thyroiditis in an Incidence Cohort: Olmsted County, Minnesota, Study". The Journal of Clinical Endocrinology & Metabolism. 88 (5): 2100–2105. doi:10.1210/jc.2002-021799. ISSN   0021-972X.
  7. 1 2 3 Bindra, Archana; Braunstein, Glenn D. (2006-05-15). "Thyroiditis". American Family Physician. 73 (10): 1769–1776. ISSN   0002-838X. PMID   16734054.
  8. ↑ Pearce, Elizabeth N.; Farwell, Alan P.; Braverman, Lewis E. (2003-06-26). "Thyroiditis". New England Journal of Medicine. 348 (26). Massachusetts Medical Society: 2646–2655. doi:10.1056/nejmra021194. ISSN   0028-4793.
  9. ↑ Eylan, E.; Zmucky, R.; Sheba, Ch. (1957). "MUMPS VIRUS AND SUBACUTE THYROIDITIS". The Lancet. 269 (6978): 1062–1063. doi:10.1016/S0140-6736(57)91438-1.
  10. 1 2 BUCHTA, RICHARD M. (1980-11-01). "Subacute Thyroiditis in a 4½-Year-Old Girl". Archives of Pediatrics & Adolescent Medicine. 134 (11). American Medical Association (AMA): 1090. doi:10.1001/archpedi.1980.02130230068019. ISSN   1072-4710.
  11. ↑ Volta, Cecilia; Carano, Nicola; Street, Maria Elisabeth; Bernasconi, Sergio (2005). "Atypical Subacute Thyroiditis Caused by Epstein-Barr Virus Infection in a Three-Year-Old Girl". Thyroid. 15 (10): 1189–1191. doi:10.1089/thy.2005.15.1189. ISSN   1050-7256.
  12. ↑ Al Maawali, A.; Al Yaarubi, S.; Al Futaisi, A. (2008). "An Infant with Cytomegalovirus-induced Subacute Thyroiditis". Journal of Pediatric Endocrinology and Metabolism. 21 (2). Walter de Gruyter GmbH. doi:10.1515/jpem.2008.21.2.191. ISSN   2191-0251.
  13. ↑ Brouqui, P.; Raoult, D.; Conte-Devolx, B. (1991-06-15). "Coxsackie Thyroiditis". Annals of Internal Medicine. 114 (12). American College of Physicians: 1063–1064. doi:10.7326/0003-4819-114-12-1063_2. ISSN   0003-4819.
  14. ↑ Volpé, Robert; Row, Vas V.; Ezrin, Calvin (1967). "Circulating Viral and Thyroid Antibodies in Subacute Thyroiditis 1". The Journal of Clinical Endocrinology & Metabolism. 27 (9): 1275–1284. doi:10.1210/jcem-27-9-1275. ISSN   0021-972X.
  15. 1 2 Desailloud, Rachel; Hober, Didier (2009). "Viruses and thyroiditis: an update". Virology Journal. 6 (1): 5. doi: 10.1186/1743-422X-6-5 . ISSN   1743-422X. PMC   2654877 . PMID   19138419.
  16. ↑ Bech, Karine; Lumholtz, Bo; Nerup, Jørn; Thomsen, Mogens; Platz, Per; Ryder, Lars P.; Svejgaard, Arne; Siersbæk-Nielsen, Kaj; Hansen, Jens Mølholm; Larsen, Jørgen Hannover (1977). "HLA ANTIGENS IN GRAVES' DISEASE". Acta Endocrinologica. 86 (3): 510–516. doi:10.1530/acta.0.0860510. ISSN   0804-4643.
  17. ↑ NYULASSY, ŠTEFAN; HNILICA, PETER; BUC, MILAN; GUMAN, MILAN; HIRSCHOVÁ, VIERA; JÁN, ŠTEFANOVIC (1977). "Subacute (de Quervain's) Thyroiditis: Association with HLA-Bw35 Antigen and Abnormalities of the Complement System, Immunoglobulins and Other Serum Proteins". The Journal of Clinical Endocrinology & Metabolism. 45 (2). The Endocrine Society: 270–274. doi:10.1210/jcem-45-2-270. ISSN   0021-972X.
  18. ↑ RUBIN, ROBERT A.; GUAY, ANDRÉ T. (1991). "Susceptibility to Subacute Thyroiditis Is Genetically Influenced: Familial Occurrence in Identical Twins". Thyroid. 1 (2). Mary Ann Liebert Inc: 157–161. doi:10.1089/thy.1991.1.157. ISSN   1050-7256.
  19. ↑ DE BRUIN, TJERK W. A.; RIEKHOFF, FRANS P. M.; DE BOER, JOHANNES J. (1990). "An Outbreak of Thyrotoxicosis due to Atypical Subacute Thyroiditis*". The Journal of Clinical Endocrinology & Metabolism. 70 (2). The Endocrine Society: 396–402. doi:10.1210/jcem-70-2-396. ISSN   0021-972X.
  20. ↑ Ohsako, N; Tamai, H; Sudo, T; Mukuta, T; Tanaka, H; Kuma, K; Kimura, A; Sasazuki, T (1995). "Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing". The Journal of Clinical Endocrinology & Metabolism. 80 (12). The Endocrine Society: 3653–3656. doi:10.1210/jcem.80.12.8530615. ISSN   0021-972X.
  21. ↑ Kojima, Masaru; Nakamura, Shigeo; Oyama, Tetsunari; Sugihara, Shiro; Sakata, Noriyuki; Masawa, Nobuhide (2002). "Cellular Composition of Subacute Thyroiditis. An Immunohistochemical Study of Six Cases". Pathology — Research and Practice. 198 (12). Elsevier BV: 833–837. doi:10.1078/0344-0338-00344. ISSN   0344-0338.
  22. ↑ AMINO, NOBUYUKI; YABU, YUKIKO; MIKI, TETSURO; MORIMOTO, SHIGETO; KUMAHARA, YUICHI; MORI, HIDEMITSU; IWATANI, YOSHINORI; NISHI, KEIKO; NAKATANI, KIYOMI; MIYAI, KIYOSHI (1981). "Serum Ratio of Triiodothyronine to Thyroxine, and Thyroxine-Binding Globulin and Calcitonin Concentrations in Graves' Disease and Destruction- Induced Thyrotoxicosis*". The Journal of Clinical Endocrinology & Metabolism. 53 (1). The Endocrine Society: 113–116. doi:10.1210/jcem-53-1-113. ISSN   0021-972X.
  23. ↑ Madeddu, G.; Casu, A. R.; Costanza, C.; Marras, G.; Arras, M. L.; Marrosu, A.; Langer, M. (1985). "Serum thyroglobulin levels in the diagnosis and follow-up of subacute 'painful' thyroiditis. A sequential study". Archives of Internal Medicine. 145 (2): 243–247. ISSN   0003-9926. PMID   3977482.
  24. ↑ OMORI, Nariko; OMORI, Kazue; TAKANO, Kazue (2008). "Association of the Ultrasonographic Findings of Subacute Thyroiditis with Thyroid Pain and Laboratory Findings". Endocrine Journal. 55 (3). Japan Endocrine Society: 583–588. doi:10.1507/endocrj.k07e-163. ISSN   0918-8959.
  25. ↑ HIROMATSU, YUJI; ISHIBASHI, MASATOSHI; MIYAKE, IKUYO; SOYEJIMA, ERI; YAMASHITA, KIMIKO; KOIKE, NORIMASA; NONAKA, KYOHEI (1999). "Color Doppler Ultrasonography in Patients with Subacute Thyroiditis". Thyroid. 9 (12). Mary Ann Liebert Inc: 1189–1193. doi:10.1089/thy.1999.9.1189. ISSN   1050-7256.
  26. ↑ Walfish, P. G. (1997). "Thyroiditis". Current Therapy in Endocrinology and Metabolism. 6: 117–122. ISSN   0831-652X. PMID   9174718.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.